Myocardial infarction (MI) is a type of cardiovascular disease that occurs when the blood supply to the heart is blocked, leading to the death of heart muscle tissue. It is the most common type of heart attack and is a major cause of death and disability worldwide. Treatment for MI typically involves medications, lifestyle changes, and in some cases, surgery.
The MI market within the context of cardiology is a rapidly growing sector, driven by the increasing prevalence of cardiovascular diseases and the need for better treatments. The market is expected to benefit from the development of new technologies and treatments, such as stem cell therapy and gene therapy. Additionally, the increasing demand for minimally invasive procedures is expected to drive the market growth.
Some of the key players in the MI market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Johnson & Johnson, St. Jude Medical, and Biotronik. Show Less Read more
